FDA approves first-in-class SYK inhibitor

被引：0

|

作者：

Asher Mullard

机构：

来源：

Nature Reviews Drug Discovery | 2018年 / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：385 / 385

相关论文

共 50 条

[1] FDA approves first-in-class SYK inhibitor
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (06) : 385 - 385
[2] FDA approves first-in-class AKT inhibitor
Asher Mullard
Nature Reviews Drug Discovery, 2024, 23 : 9 - 9
[3] FDA approves first-in-class AKT inhibitor
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (01) : 9 - 9
[4] FDA approves first-in-class HIV capsid inhibitor
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 90 - 90
[5] FDA approves first-in-class HIV capsid inhibitor
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (02) : 90 - 90
[6] FDA approves first-in-class osteoporosis drug
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (06) : 411 - 411
[7] FDA approves first-in-class osteoporosis drug
Asher Mullard
Nature Reviews Drug Discovery, 2019, 18 (6) : 411 - 411
[8] FDA approves first-in-class bispecific for multiple myeloma
不详
NATURE BIOTECHNOLOGY, 2023, 41 (09) : 1181 - 1181
[9] FDA approves first-in-class cancer metabolism drug
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 593 - 593
[10] FDA approves first-in-class bispecific for multiple myeloma
Nature Biotechnology, 2023, 41 : 1180 - 1180

← 1 2 3 4 5 →